AICF's 2020-21 Fellow:
Marta Collu, PhD
Targeting BRCAness in non-small cell lung carcinoma (NSCLC)
"I conducted my doctoral studies between Italy and Switzerland, and I obtained my PhD in Drug Sciences in 2019 from the University of Cagliari. During this research experience, I become increasingly passionate about investigating the molecular mechanisms underlying the cellular transitions from healthy to pathological states, and how these can be exploited therapeutically. To pursue my research interests, I joined the Pagano Laboratory at the New York University School of Medicine and the Howard Hughes Medical Institute. With the support of the AICF Post-doctoral Research Fellowship, I will study the interplay between defects in the homologous recombination repair and the use of FDA-approved PARP inhibitors in NSCLC."